XML 90 R77.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Equity Incentive Plans (Details) - Schedule of Consolidated Statements of Operations and Comprehensive Loss Include Stock-Based Compensation Expense - Stock Option [Member] - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Schedule of Consolidated Statements of Operations and Comprehensive Loss Include Stock-Based Compensation Expense [Line Items]        
Cost of revenue $ 11 $ 22
Research and development 274 541 775 1,083
Selling, general and administrative 1,167 5,227 13,371 8,530
Total stock-based compensation expense $ 1,441 $ 5,779 $ 14,146 $ 9,635